Close

Heidi Hopkins

MD

Associate Professor

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Since 2003, my professional focus has been clinical and implementation research on malaria diagnostic strategies and management of febrile patients in malaria-endemic areas. These interests have led to current work on fever etiology and antimicrobial resistance. I head the Clinical & Veterinary Sciences pillar of LSHTM’s Antimicrobial Resistance Centre.

Previous affiliations include the Foundation for Innovative New Diagnostics (FIND) in Uganda and Switzerland, and the Makerere University – University of California, San Francisco malaria research collaboration in Uganda.

My educational history includes degrees in anthropology (BA, University of Iowa), medicine (MD, Columbia College of Physicians & Surgeons, New York), and coursework in public health (University of California, Berkeley), as well as clinical training in internal medicine (Columbia-Presbyterian Medical Center, New York) and infectious diseases (University of California, San Francisco).

Affiliations

Department of Disease Control
Faculty of Infectious and Tropical Diseases

Centres

Malaria Centre
Antimicrobial Resistance Centre

Teaching

I teach on LSHTM's Epidemiology & Control of Malaria module; the Epidemiology & Control of Communicable Disease module; the Infectious Disease Research Design, Management & Analysis course; and as of 2019, the Diploma in Tropical Medicine & Hygiene course. I also mentor Master's and doctoral students.

Research

I have served as investigator and coordinator for numerous efficacy, effectiveness, and implementation studies of point-of-care diagnostic tests in children, adults and pregnant women, and for evaluations of fever case management strategies. I have been based primarily in Uganda, and have also conducted collaborative research in other African and southeast Asian countries.

In 2018 we began FIEBRE (Febrile Illness Evaluation in a Broad Range of Endemicities), a prospective study of infectious causes of fever, and of antibiotic resistance, in inpatients and outpatients of all ages at multiple sites in Africa and Asia.

Other current projects include synthesis of research results from ACT Consortium studies of malaria rapid diagnostic test (mRDT) implementation in various endemic settings; investigation of pfhrp2/3 gene deletions in P. falciparum samples from Africa and Asia; and a collaborative effort to map data on non-malaria febrile illness.

My work includes collaboration with other academic researchers as well as with scientists and public health experts from the WHO, non-profit organizations, funding agencies, and diagnostics developers.

 

Selected publications:

  1. O’Boyle S, Bruxvoort KJ, Ansah E, Burchett HED, Chandler CIR, Clarke SE, Goodman C, Mbacham W, Mbonye AK, Onwujekwe OE, Staedke SG, Wiseman VL, Whitty CJM, Hopkins H. Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa. BMC Medicine, Jan 2020.
  2. Mather RG, Hopkins H, Parry CM, Dittrich S. Redefining typhoid diagnosis: what would an improved test need to look like? BMJ Glob Health, Oct 2019.
  3. Thomson R, Beshir KB, Cunningham J, Baiden F, Bharmal J, Bruxvoort KJ, Maiteki-Sebuguzi C, Owusu-Agyei S, Staedke SG, Hopkins H. pfhrp2 and pfhrp3 gene deletions that affect malaria rapid diagnostic tests for Plasmodium falciparum: analysis of archived blood samples from three African countries. J Infect Dis, Jun 2019.
  4. Bruxvoort KJ, Leurent B, Chandler CIR, [ACT Consortium RDTs in Context Working Group], Schellenberg D, Hopkins H. The impact of introducing malaria rapid diagnostic tests on fever case management: A synthesis of ten studies from the ACT Consortium. AJTMH, Oct 2017.
  5. Hopkins H, Bruxvoort KJ, Cairns M, [ACT Consortium RDTs in Context Working Group], Staedke SG, Whitty CJM. The impact of introducing malaria rapid diagnostic tests on antibiotic prescribing: a nine-site analysis in public and private health care settings. BMJ, April 2017.
  6. Kyabayinze DJ, Zongo I, Cunningham J, Gatton M, Angutoko P, Ategeka J, Compaoré YD, Muehlenbachs A, Mulondo J, Nakalembe M, Somé FA, Ouattara A, Rouamba N, Ouédraogo JB, Hopkins H, Bell D. HRP2 and pLDH-based rapid diagnostic tests, expert microscopy, and PCR for detection of malaria infection during pregnancy and at delivery in areas of varied transmission: a prospective cohort study in Burkina Faso and Uganda. PLoS One, Jul 2016.
  7. Mbabazi P, Hopkins H, Osilo E, Kalungu M, Byakika-Kibwika P, Kamya MR. Accuracy of two malaria rapid diagnostic tests (RDTs) for initial diagnosis and treatment monitoring in a high transmission setting in Uganda. AJTMH, Mar 2015.
  8. Odaga J, Sinclair D, Lokong JA, Donegan S, Hopkins H, Garner P. Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings. Cochrane Database Syst Rev, Apr 2014.
  9. Hopkins H, “Diagnosis of malaria” section, UpToDate, Inc., Wolters Kluwer Health; maintained since Aug 2013.
  10. Hopkins H, González IJ, Polley SD, Angutoko P, Ategeka J, Asiimwe C, Agaba B, Kyabayinze DJ, Sutherland CJ, Perkins MD, Bell D. Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis, Aug 2013.
  11. Hopkins H, Asiimwe C, Bell D. Access to antimalarial therapy: accurate diagnosis is essential to achieving long term goals. BMJ, Jul 2009.
  12. Hopkins H, Bebell L, Kambale W, Dokomajilar C, Rosenthal PJ, Dorsey G. Rapid diagnostic tests for malaria at sites of varied transmission intensity in Uganda. J Infect Dis, Feb 2008.
Disease and Health Conditions
Infectious disease
Malaria
Tropical diseases
Country
Burkina Faso
Lao PDR
Mozambique
Malawi
Uganda
Zimbabwe

Selected Publications

Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa.
O'Boyle S; Bruxvoort KJ; Ansah EK; Burchett HED; Chandler CIR; Clarke SE; Goodman C; Mbacham W; Mbonye AK; Onwujekwe OE
2020
BMC medicine
FIEBRE (FEBRILE ILLNESS EVALUATION IN A BROAD RANGE OF ENDEMICITIES): A MULTI-SITE PROSPECTIVE OBSERVATIONAL STUDY OF CAUSES OF FEVER IN SUB-SAHARAN AFRICA AND SOUTHEAST ASIA
Hopkins H; Bassat Q; Chandler CIR; Crump JA; Feasey NA; Ferrand RA; Lalloo DG; Mayxay M; Newton PN; Mabey DCW
2019
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
REDEFINING TYPHOID DIAGNOSIS: WHAT SHOULD A BETTER TEST LOOK LIKE, AND WHAT INNOVATIONS ARE AVAILABLE TO MEET THE NEEDS?
Mather R; Dailey PJ; Hopkins H; Dittrich S
2019
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
Redefining typhoid diagnosis: what would an improved test need to look like?
Mather RG; Hopkins H; Parry CM; Dittrich S
2019
BMJ Global Health
Redefining typhoid diagnosis: what would an improved test need to look like?
Mather RG; Hopkins H; Parry CM; Dittrich S
2019
BMJ Global Health
EMERGENCE OF DIMINISHED CIPROFLOXACIN-SUSCEPTIBILITY SALMONELLA TYPHI IN AN ONGOING OUTBREAK FROM HARARE, ZIMBABWE
Olaru ID; Feasey N; Ferrand R; Mabey D; Hopkins H; Zinyowera S; Amos B; Tarupiwa A; Mashe T; Kranzer K
2019
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
pfhrp2 and pfhrp3 Gene Deletions That Affect Malaria Rapid Diagnostic Tests for Plasmodium falciparum: Analysis of Archived Blood Samples From 3 African Countries.
Thomson R; Beshir KB; Cunningham J; Baiden F; Bharmal J; Bruxvoort KJ; Maiteki-Sebuguzi C; Owusu-Agyei S; Staedke SG; Hopkins H
2019
The Journal of Infectious Diseases
Global analysis of Plasmodium falciparum histidine-rich protein-2 (pfhrp2) and pfhrp3 gene deletions using whole-genome sequencing data and meta-analysis.
Sepúlveda N; Phelan J; Diez-Benavente E; Campino S; Clark TG; Hopkins H; Sutherland C; Drakeley CJ; Beshir KB
2018
Infection, genetics and evolution
See more Publications